Skip to search.
 TSX Up 0.08% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On CNJ.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Cangene Corporation (CNJ.TO)

-Toronto

2.97 Up 0.01(0.34%) May 22, 1:42PM EDT

Add to Portfolio
Prev Close:2.96
Open:2.97
Bid:2.95
Ask:2.99
1y Target Est:2.60
Beta:N/A
Next Earnings Date:12-Jun-13CNJ.TO Earnings announcement
Day's Range:2.95 - 2.97
52wk Range:1.40 - 3.28
Volume:5,105
Avg Vol (3m):21,077
Market Cap:198.24M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Comparison

Symbol% ChgMkt Cap
CNJ.TOUp 0.34%198.24M
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 0.94%11.88B
SUNPHARMA.NSDown 0.20%1.04T
GILD.MXDown 0.83%1.06T

Key Statistics

Forward P/E (1 yr):12.38
P/S (ttm):1.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jul-13) :0.06
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cangene Corporation, a biopharmaceutical company, develops, manufactures, and commercializes immune therapeutics primarily in Canada and the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback